Unmet Needs for Patients With HR+, HER2- Early Breast Cancer at a High Risk of Recurrence
By
Lilly Medical Affairs
FEATURING
Hope Rugo
By
Lilly Medical Affairs
FEATURING
Hope Rugo
Watch as Dr. Hope Rugo shares critical insights on managing and reducing the risk of HR+, HER2- breast cancer recurrence, particularly in patients with early-stage disease to better individualize treatment plans.
To access additional videos and download free resources click here.
VV-OTHR-US-DEL-3291 © 2024 Lilly USA, LLC. All Rights Reserved.
Comments are disabled for this content.
